Glynn Weldon Gilcrease Iii BA, BS, MD

Dr. G. Weldon Gilcrease, MD is an Assistant Professor in the oncology division at the University of Utah School of Medicine and a Huntsman Cancer Institute (HCI) investigator. He specializes in gastrointestinal cancers and patients enrolled in early phase trials. Dr. Gilcrease is also the Program Director for the Hematology/Oncology Fellowship program at the University of Utah School of Medicine and a Huntsman Cancer Institute (HCI).
Dr. Gilcrease focuses on early phase clinical trials and drug development. He is involved in preclinical research and Phase I/II trials for patients affected with inoperable colorectal cancer. His research entails exploiting important pathways that drive cancer, including the beta-catenin pathway in colorectal cancer. He hopes to bring novel and targeted therapies into the clinic to benefit patients.